Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene tumor initiation and its relationship to DNA binding.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000818:Animals; D001551:Benz(a)Anthracenes / Q000037:antagonists & inhibitors*; D001580:Benzopyrenes / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004247:DNA / Q000378:metabolism*; D004147:Dioxins / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D051379:Mice; D009374:Neoplasms, Experimental / Q000517:prevention & control; D010212:Papilloma / Q000139:chemically induced / Q000517:prevention & control*; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology*; D012867:Skin / Q000378:metabolism; D012878:Skin Neoplasms / Q000139:chemically induced / Q000517:prevention & control*
D001551:Benz(a)Anthracenes; D001580:Benzopyrenes; D004147:Dioxins; D000072317:Polychlorinated Dibenzodioxins; D015127:9,10-Dimethyl-1,2-benzanthracene; D004247:DNA